BI 765883
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BI 765883, covering 2026-02-03 to 2026-07-15. Get the full timeline:
Most recent: Clinical Trial Results: A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy [Phase 1]